Company Filing History:
Years Active: 2017
Title: Kamila Pytel: Innovator in Polypeptide Research
Introduction
Kamila Pytel is a distinguished inventor based in Birmingham, GB. She has made significant contributions to the field of biotechnology, particularly in the development of polypeptides that modulate cell behavior. Her innovative work has the potential to impact medical treatments and therapies.
Latest Patents
Kamila Pytel holds a patent for her invention titled "Polypeptides and use thereof." This patent describes polypeptides capable of modulating tissue transglutaminase-induced cell behavior. The polypeptide comprises or consists of either (a) the amino acid sequence of a heparin-binding site of a tissue transglutaminase or a functional fragment, variant, fusion, or derivative thereof. Alternatively, it may include (b) an antibody capable of binding to a heparin-binding site of a tissue transglutaminase, or an antigen-binding fragment or derivative thereof. The invention further outlines medical uses of these polypeptides and methods of treatment utilizing them. Kamila has 1 patent to her name.
Career Highlights
Kamila Pytel is affiliated with Aston University, where she conducts her research and development work. Her academic background and research focus have positioned her as a key figure in her field.
Collaborations
Kamila has collaborated with notable colleagues, including Russell Collighan and Martin Griffin. Their combined expertise enhances the research and development efforts in their projects.
Conclusion
Kamila Pytel is a pioneering inventor whose work in polypeptide research holds promise for advancing medical treatments. Her contributions to biotechnology are noteworthy and reflect her commitment to innovation in the field.